Antimicrobial susceptibility patterns of Staphylococcus aureus and characterization of MRSA in Southwestern Nigeria

Wounds

Volumn 18, Issue 4, 2006, Pages 77-84

  Shittu, Adebayo ^a,b   Lin, Johnson ^b   Kolawole, Deboye ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33744467965     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Tenover FC, Gaynes RP. The epidemiology of Staphylococcus infections. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JL, eds. Gram-Positive Pathogens. Washington, DC: American Society for Microbiology, 2000:414-421.
2. Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol. 2005;43(5):2384-2390.
3. Guven GS, Uzun O. Principles of good use of antibiotics in hospitals. J Hosp Infect. 2003;53(2):91-96.
4. Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest. 2003;111(9):1265-1273.
5. Ako-Nai AK, Taiwo O, Ebri A, Adeniran MO. Bacterial isolates involved in cases of septicaemia in a Nigerian hospital. East Afr Med J. 1990;67(6):407-412.
6. Unachukwu CN, Obunge OK, Odia OJ. The bacteriology of diabetic foot ulcers in Port Harcourt, Nigeria. Niger J Med. 2005;14(2):173-176.
7. Ako-Nai AK, Ogunniyi AD, Lamikanra A, Torimiro SE. The characterization of clinical isolates of Staphylococcus aureus in Ile-Ife, Nigeria. J Med Microbiol. 1991;34(2):109-112.
8. Ako-Nai AK, Lamikanra AB, Onipede AO. Incidence of pathogenic microorganisms in clinical specimens from hospitals in south-western Nigeria. East Afr Med J. 1995;72(7):436-441.
9. Oni AA, Bakare RA, Okesola AO, Ogunlowo HA, Ewete AF. Pattern of bacterial pathogens in surgical wound infections. Afr J Med Med Sci. 1997;26(3-4):139-140.
10. Emele FE, Izomoh MI, Alufohai E. Microorganisms associated with wound infection in Ekpoma, Nigeria. West Afr J Med. 1999;18(2):97-100.
11. Adejuyigbe EA, Adeodu OO, Ako-Nai KA, Taiwo O, Owa JA. Septicaemia in high risk neonates at a teaching hospital in Ile-Ife, Nigeria. East Afr Med J. 2001;78(10):540-543.
12. Ako-Nai AK, Oluga FA, Onipede AO, Adejuyigbe EA, Amusa YB. The characterization of bacterial isolates from acute otitis media in Ile-Ife, southwestern Nigeria. J Trop Pediatr. 2002;48(1):15-23.
13. Odusanya OO. Antibiotic susceptibility of microorganisms at a general hospital in Lagos, Nigeria. J Natl Med Assoc. 2002;94(11):994-998.
14. National Committee for Clinical Laboratory Standards (now CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests. NCCLS document M2-A8. Wayne, Pa: National Committee for Clinical Laboratory Standards; 2003.
15. Skov R, Frimodt-Moller N, Espersen F. Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagn Microbiol Infect Dis. 2001;40(3):111-116.
16. Kim HB, Jang HC, Nam HJ, et al. In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother. 2004;48(4):1124-1127.
17. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol. 2003;41(10):4740-4744.
18. Udo EE, Farook VS, Mokadas EM, Jacob LE, Sanyal SC. Molecular fingerprinting of mupirocin-resistant methicillin-resistant Staphylococcus aureus from a burn unit. Int J Infect Dis. 1999;3(2):82-87.
19. Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol. 1992;30(7):1654-1660.
20. Bignardi GE, Woodford N, Chapman A, Johnson AP, Speller DC. Detection of the mec-A gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance. J Antimicrob Chemother. 1996;37(1):53-63.
21. Woodford N, Watson AP, Patel S, Jevon M, Waghorn DJ, Cookson BD. Heterogeneous location of the mupA high-level mupirocin resistance gene in Staphylococcus aureus. J Med Microbiol. 1998;47(9):829-835.
22. Bannerman TL, Hancock GA, Tenover FC, Miller JM. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol. 1995;33(3):551-555.
23. Jorgensen M, Givney R, Pegler M, Vickery A, Funnell G. Typing multidrug-resistant Staphylococcus aureus: conflicting epidemiological data produced by genotypic and phenotypic methods clarified by phylogenetic analysis. J Clin Microbiol. 1996;34(2):398-403.
24. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46(7):2155-2161.
25. Bouchillon SK, Johnson BM, Hoban DJ, et al. Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents. 2004;24(2):119-124.
26. Enright MC. The evolution of a resistant pathogen - the case of MRSA. Curr Opin Pharmacol. 2003;3(5):474-479.
27. Tenover FC, Lancaster MV, Hill BC, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol. 1998;36(4):1020-1027.
28. Matynia B, Mlodzinska E, Hryniewicz W. Antimicrobial susceptibility patterns of Staphylococcus aureus in Poland obtained by the National Quality Assurance Programme. Clin Microbiol Infect. 2005;11(5):379-385.
29. Okeke IN, Lamikanra A. Quality and bioavailability of tetracycline capsules in a Nigerian semi-urban community. Int J Antimicrob Agents. 1995;5(4):245-250.
30. Okeke IN. Factors contributing to the emergence of resistance. In: Knobler SL, Lemon SM, Najafi M, Burroughs T, eds. The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment-Workshop Summary. Washington, DC: The National Academies Press; 2003:132-139.
31. Rotimi VO, Orebamjo OA, Banjo TO, Onyenefa PI, Nwobu RN. Occurrence and antibiotic susceptibility profiles of methicillin-resistant Staphylococcus aureus in Lagos University Teaching Hospital. Cent Afr J Med. 1987;33(4):95-99.
32. Okesola AO, Oni AA, Bakare RA. Prevalence and antibiotic sensitivity pattern of methicillin-resistant Staphylococcus aureus in Ibadan, Nigeria. J Hosp Infect. 1999;41(1):74-75.
33. Kesah C, Ben Redjeb S, Odugbemi TO, et al. Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Clin Microbiol Infect. 2003;9(2):153-156.
34. Taiwo SS, Onile BA, Akanbi AA. Methicillin-resistant Staphylococcus aureus (MRSA) isolates in florin, Nigeria. Afr J Clin Exper Microbiol. 2004;5(2):189-197.
35. Adesida S, Boelens H, Babajide B, et al. Major epidemic clones of Staphylococcus aureus in Nigeria. Microb Drug Resist. 2005;11(2):115-121.
36. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA. 2002;99(11):7687-7692.
37. Cookson BD. Antiseptic resistance in methicillin-resistant Staphylococcus aureus: an emerging problem. Int J Med Microbiol. 1994;26(Suppl):227-234.
38. Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother. 1998;41(1):11-18.
39. Perez-Roth E, Claverie-Martin F, Batista N, Moreno A, Mendez-Alvarez S. Mupirocin resistance in methicillin-resistant Staphylococcus aureus clinical isolates in a Spanish hospital. Co-application of multiplex PCR assay and conventional microbiology methods. Diagn Microbiol Infect Dis. 2002;43(2):123-128.
40. O'Neill GL, Murchan S, Gil-Setas A, Aucken HM. Identification and characterization of phage variants of a strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-15). J Clin Microbiol. 2001;39(4):1540-1548.
41. Witte W, Enright M, Schmitz FJ, Cuny C, Braulke C, Heuck D. Characteristics of a new epidemic MRSA in Germany ancestral to United Kingdom EMRSA 15. Int J Med Microbiol. 2001;290(8):677-682.
42. Moore PCL, Lindsay JA. Molecular characterization of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16. J Med Microbiol. 2002;51(6):516-521.
43. Melter O, Aires de Sousa M, Urbaskova P, Jakubu V, Zemlickova H, de Lencastre H. Update on the major clonal types of methicillin-resistant Staphylococcus aureus in the Czech Republic. J Clin Microbiol. 2003;41(11):4998-5005.
44. Perez-Roth E, Lorenzo-Diaz F, Batista N, Moreno A, Mendez-Alvarez S. Tracking methicillin-resistant Staphylococcus aureus clones during a 5-year period (1998 to 2002) in a Spanish hospital. J Clin Microbiol. 2004;42(10):4649-656.
45. Udo EE, Al-Sweih N, Noronha B. Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals. Clin Microbiol Infect. 2006;12(3):262-269.